MATA NATHAN L. sold BLTE

May 4, 2026 · Form 4 insider transaction

MATA NATHAN L. sold 325 shares of Belite Bio, Inc at $155.21 per share, a transaction worth $50.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
325
Price
$155.21
Total value
$50.4K
RoleOfficer
SecurityAmerican depositary share
Transaction codeS: Open-market sale
Transaction dateMay 4, 2026
Filing dateMay 5, 2026
Shares owned after3,073
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.; The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.; Represents the weighted average price of shares sold at prices that ranged from $155.02 to $155.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
MATA NATHAN L. sold BLTE: May 4, 2026 | Insider Trading Screener